Antonin Schmitt

Antonin Schmitt

Université de Bourgogne - Dijon / France
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 924195
University of Burgundy
person_outline Antonin Schmitt's MOST POPULAR ARTICLES
1-) Abstract CT-01: BYL719, a next generation PI3K alpha specific inhibitor: Preliminary safety, PK, and efficacy results from the first-in-human studyD Juric, J Rodon, AM Gonzalez-Angulo, HA Burris, J Bendell, JD Berlin, ...Cancer research 72 (8 Supplement), CT-01-CT-01, 2012922012
2-) Dihydropyrimidine dehydrogenase (DPD) deficiency screening and securing of fluoropyrimidine-based chemotherapies: update and recommendations of the French GPCO-Unicancer and …MA Loriot, J Ciccolini, F Thomas, C Barin-Le-Guellec, B Royer, G Milano, ...Bulletin du cancer 105 (4), 397-407, 2018622018
3-) Factors for hematopoietic toxicity of carboplatin: refining the targeting of carboplatin systemic exposureA Schmitt, L Gladieff, CM Laffont, A Evrard, JC Boyer, A Lansiaux, ...Journal of Clinical Oncology 28 (30), 4568-4574, 2010622010
4-) A universal formula based on cystatin C to perform individual dosing of carboplatin in normal weight, underweight, and obese patientsA Schmitt, L Gladieff, A Lansiaux, C Bobin-Dubigeon, ...Clinical Cancer Research 15 (10), 3633-3639, 2009562009
5-) 5-FU therapeutic drug monitoring as a valuable option to reduce toxicity in patients with gastrointestinal cancerK Morawska, F Goirand, L Marceau, M Devaux, A Cueff, A Bertaut, ...Oncotarget 9 (14), 11559, 2018502018